Well Referenced

Tag: Malignancy

Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in adults

This nationwide cohort study from the Netherlands analyzed the impact of growth hormone (GH) replacement therapy on mortality in adults with GH deficiency (GHD). The study included 2,229 GH-treated patients, 109 untreated patients, and 356 partially treated patients. Results showed that GH-treated men had mortality rates comparable to the general

Read More »
June 26, 2025 No Comments

Long-term safety of growth hormone—a combined registry analysis

This comprehensive analysis reviewed data from multiple growth hormone (GH) registries to assess the long-term safety of GH treatment in children and adults. The study found no increased risk of mortality, stroke, or new malignancies in GH-treated individuals without pre-existing risk factors. However, an elevated risk of secondary neoplasms was

Read More »
June 26, 2025 No Comments